Benha University
Banhā, Other, 13511, Egypt
NCT Number: NCT05389891
Hemoglobinopathies are the most common life threatening, monogenic disorders in the world. The most common causes of hemoglobinopathies are sickle cell disease and thalassemia. Aim: This study aimed to evaluate the effect of a hemoglobinopathy nursing program on pediatric nursing students' performance.
Looking for future studies?
Notify Me19 year–22 year
All sexes
Interventional
Not applicable
Banhā, Other, 13511, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
"Hemoglobinopathy Nursing Program" is more informative for "Groupe 1" than "Group 2"
Time frame: 10 weeks
Measure Students' awareness through:
-sixty (60) questions. A score of (one) for correct answers, and (zero) for the wrong answers. The total scores ranged from (0-60 mark).
Time frame: 10 weeks
Pediatric nursing students' Attitude Scale
Time frame: 10 weeks
Observational Checklists - forty (40) items. A score of (two) for completely done, (one) for incompletely done and (zero) for not done. The total score ranged from (0-80 mark), scores less than 60% were considered incompetent practice.
Beni-Suef University
Other
Effect of a Hemoglobinopathy Nursing Program on Pediatric Student Nurses' Awareness and Performance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03609840
Anemia, Anemia, Aplastic
San Francisco, California, United States
View Trial DetailsNCT03609814
Anemia, Anemia, Aplastic
San Francisco, California, United States
View Trial DetailsNCT01316549
Anemia, Anemia, Aplastic
San Francisco, California, United States
View Trial DetailsNCT03609827
Anemia, Anemia, Aplastic
San Francisco, California, United States
View Trial Details